Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Comprehensive Analysis of Chemical Ingredients of Waiganfengsha Granule and Absorbed Components in Rat Plasma Based on UHPLC-Q-TOF-MS

Author(s): Wei Wei, Liyuan Huang, Jun Huang, Jinhua Li, Yingying Qing, Xiaotao Hou* and Wen Liu*

Volume 25, Issue 3, 2024

Published on: 23 May, 2024

Page: [205 - 219] Pages: 15

DOI: 10.2174/0113892002299899240515092703

Price: $65

Abstract

Objective: Waiganfengsha Granule, an over-the-counter drug, is commonly used for treating windheat cold and sore throat in clinical settings. However, its material basis of medicinal efficacy is still unclear. In this study, an efficient integrated analytical strategy was established for its chemical and metabolite profiles study.

Methods: Firstly, to avoid the possible false-positive results of structural elucidation, an in-house component library that contains chemical constituents reported in the literature from the six individual medicines of Waiganfengsha Granule was established. Secondary, mass data post-processing techniques, including precursor ion list and neutral loss filtering, were applied to enhance the identification accuracy. Thirdly, for the rapid characterization of those absorbed components after oral administration in rats, the identified chemical constituents were used as candidate components for the serum analysis. By comparing the retention time and analyzing mass data, the metabolites in rat plasma were identified.

Results: As a result, 57 chemical ingredients were identified, including 21 phenolic acids, 9 alkaloids, 2 flavonoids, 5 lignins, 13 saponins, and 7 other compounds. Among these, 12 compounds were unambiguously identified by comparison with reference standards, and 45 were tentatively characterized by analyzing their accurate MS data, MS/MS fragmentation patterns, and also by comparison with those data reported in the literature. Additionally, 46 metabolites were detected and identified in rat plasma.

Conclusion: This study is beneficial for understanding the chemical composition and metabolic profiles of Waiganfengsha Granule, and the results obtained might provide a solid basis for further studies on its functional mechanism.

« Previous Next »
[1]
Ruchawapol, C.; Fu, W.W.; Xu, H.X. A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19. Phytomedicine, 2022, 104, 154324.
[http://dx.doi.org/10.1016/j.phymed.2022.154324] [PMID: 35841663]
[2]
Luo, L.; Jiang, J.; Wang, C.; Fitzgerald, M.; Hu, W.; Zhou, Y.; Zhang, H.; Chen, S. Analysis on herbal medicines utilized for treatment of COVID-19. Acta Pharm. Sin. B, 2020, 10(7), 1192-1204.
[http://dx.doi.org/10.1016/j.apsb.2020.05.007] [PMID: 32834949]
[3]
Xie, Y.; Luo, J.; Wang, Y.; Luo, G.; Wang, S. Research progress and prospect on the effective material basis and related mechanism of Traditional Chinese Medicine driven by systematic thinking. J. Holistic Integrative Pharmacy, 2022, 3(2), 206-216.
[http://dx.doi.org/10.1016/S2707-3688(23)00059-6]
[4]
Bu, L.; Dai, O.; Zhou, F.; Liu, F.; Chen, J.F.; Peng, C.; Xiong, L. Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis. Biomed. Pharmacother., 2020, 132, 110855.
[http://dx.doi.org/10.1016/j.biopha.2020.110855] [PMID: 33059257]
[5]
Yu, Y.; Yao, C.; Guo, D. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography−mass spectrometry. Acta Pharm. Sin. B, 2021, 11(6), 1469-1492.
[http://dx.doi.org/10.1016/j.apsb.2021.02.017] [PMID: 34221863]
[6]
Zhang, W.J.; Wang, S.; Kang, C.; Lv, C.; Zhou, L.; Huang, L.Q.; Guo, L.P. Pharmacodynamic material basis of traditional Chinese medicine based on biomacromolecules: A review. Plant Methods, 2020, 16(1), 26.
[http://dx.doi.org/10.1186/s13007-020-00571-y] [PMID: 32140174]
[7]
Yang, K.; Long, X.M.; Cao, J.J.; Li, Y.J.; Wu, Y.; Bai, X.; Sun, Z.L.; Liu, Z.Y. An analytical strategy to explore the multicomponent pharmacokinetics of herbal medicine independently of standards: Application in Gelsemium elegans extracts. J. Pharm. Biomed. Anal., 2019, 176, 112833.
[http://dx.doi.org/10.1016/j.jpba.2019.112833] [PMID: 31473492]
[8]
Mollerup, C.B.; Dalsgaard, P.W.; Mardal, M.; Linnet, K. Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Drug Test. Anal., 2017, 9(7), 1052-1061.
[http://dx.doi.org/10.1002/dta.2120] [PMID: 27750404]
[9]
Wang, Y.; Feng, R.; Wang, R.; Yang, F.; Li, P.; Wan, J.B. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list. Anal. Chim. Acta, 2017, 992, 67-75.
[http://dx.doi.org/10.1016/j.aca.2017.08.044] [PMID: 29054151]
[10]
Zhang, J.Y.; Wang, F.; Zhang, H.; Lu, J.Q.; Qiao, Y.J. Rapid identification of polymethoxylated flavonoids in traditional Chinese medicines with a practical strategy of stepwise mass defect filtering coupled to diagnostic product ions analysis based on a hybrid LTQ-Orbitrap mass spectrometer. Phytochem. Anal., 2014, 25(5), 405-414.
[http://dx.doi.org/10.1002/pca.2508] [PMID: 24596165]
[11]
Dai, W.; Yin, P.; Zeng, Z.; Kong, H.; Tong, H.; Xu, Z.; Lu, X.; Lehmann, R.; Xu, G. Nontargeted modification-specific metabolomics study based on liquid chromatography-high-resolution mass spectrometry. Anal. Chem., 2014, 86(18), 9146-9153.
[http://dx.doi.org/10.1021/ac502045j] [PMID: 25186149]
[12]
Zheng, C.; Hao, H.; Wang, X.; Wu, X.; Wang, G.; Sang, G.; Liang, Y.; Xie, L.; Xia, C.; Yao, X. Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-IT-TOF/MS: Shengmai injection as an example. J. Mass Spectrom., 2009, 44(2), 230-244.
[http://dx.doi.org/10.1002/jms.1502] [PMID: 18853475]
[13]
Yao, C.; Pan, H.; Wang, H.; Yao, S.; Yang, W.; Hou, J.; Jin, Q.; Wu, W.; Guo, D. Global profiling combined with predicted metabolites screening for discovery of natural compounds: Characterization of ginsenosides in the leaves of Panax notoginseng as a case study. J. Chromatogr. A, 2018, 1538, 34-44.
[http://dx.doi.org/10.1016/j.chroma.2018.01.040] [PMID: 29395157]
[14]
Li, K.; Liu, M.; Zhang, M.; Li, Q.; Yu, K.; Li, J.; Shang, Z.; Cai, W. Rapid characterization of the potential active metabolites of diacerein in rat plasma based on UHPLC-Q-exactive orbitrap mass spectrometry and molecular docking. J. Pharm. Biomed. Anal., 2023, 233, 115447.
[http://dx.doi.org/10.1016/j.jpba.2023.115447] [PMID: 37172359]
[15]
Wei, W.; Li, S.; Hao, E.; Pan, X.; Xie, J.; Du, Z.; Hou, X.; Deng, J. Rapid Chemical Profiling of Compound Huanggen Granules and Absorbed Prototypes in Cynomolgus Monkey Plasma by Integrating UHPLC-Q-TOF-MS E Method and Data Post-Processing Strategy. Curr. Drug Metab., 2022, 23(8), 652-665.
[http://dx.doi.org/10.2174/1389200223666220817112937] [PMID: 35980053]
[16]
Lin, Q.; Li, A.; Zhou, F.; Cen, J.; Huang, H. Pharmacological study on waigan fengsha granules (tablets). J. Guangxi University of Traditional Chinese Med., 2001, 4, 88-90.
[17]
Dang, H.; Li, N.; Chen, Q.; Luo, Y. Study on improving the quality standards of zhuangyao waigan fengsha granules. Popular Science & Technology, 2021, 23(05), 64-67.
[18]
Luo, Y.; Lu, S.; Tan, A.; Wu, Y.; Chen, H. Study on the quality standard of sugar free Waigan Fengsha Granules. China Modern Medicine, 2017, 24(25), 125-129.
[19]
Qin, X.; Liu, Y.; Chen, H. Orthogonal design for optimizing the one-step granulation process of sugar free Waigan Fengsha Granules. Guangxi Zhongyiyao, 2015, 38(5), 78-80.
[20]
Liu, W.; Guo, H.; Liu, J.; Qin, J.; Hu, H. Simultaneous determination of four components in Waigan Fengsha granules by HPLC. Guangxi Sciences, 2019, 26(5), 539-542.
[21]
Liu, W.; Guo, H.; Liu, J.; Luo, Y.; Wang, X. Simultaneous Determination of 9 Components in Waigan Fengsha Granules by HPLC. Zhongchengyao, 2020, 42(8), 1987-1991.
[22]
Study on the HPLC fingerprint of Waigan Fengsha granules. Asia-Pacific Traditional Medicine, 2021, 17(05), 38-41.
[23]
Liu, W.; Qin, H.; He, T.; Qin, J.; Feng, X. Study on Q-Markers of Waigan Fengsha Granules Based on Spectral-Activity Relationship. Zhongguo Yiyuan Yaoxue Zazhi, 2023, 43(17), 1920-1925.
[24]
de Villiers, A.; Venter, P.; Pasch, H. Recent advances and trends in the liquid-chromatography–mass spectrometry analysis of flavonoids. J. Chromatogr. A, 2016, 1430, 16-78.
[http://dx.doi.org/10.1016/j.chroma.2015.11.077] [PMID: 26718188]
[25]
Wu, R.; Lin, S.; Wang, J.; Tian, S.; Ke, X.; Qu, Y.; Tian, X.; Qi, X.; Ye, J.; Zhang, W. Rapid characterization of chemical constituents and metabolites of Qi-Jing-Sheng-Bai granule by using UHPLC-Q-TOF-MS. J. Sep. Sci., 2018, 41(9), 1960-1972.
[http://dx.doi.org/10.1002/jssc.201701310] [PMID: 29385310]
[26]
Yao, C.; Zhang, J.; Li, J.; Wei, W.; Wu, S.; Guo, D. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat. Prod. Rep., 2021, 38(9), 1618-1633.
[http://dx.doi.org/10.1039/D0NP00057D] [PMID: 33511969]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy